Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study)
OBJECTIVE: To assess the effects of carvedilol in patients with idiopathic dilated cardiomyopathy. METHODS: In a double-blind randomized placebo-controlled study, 30 patients (7 women) with functional class II and III heart failure were assessed. Their ages ranged from 28 to 66 years (mean of 43±9 y...
Main Authors: | Paulo Roberto Chizzola, Humberto Felício Gonçalves Freitas, Márcia Azevedo Caldas, Joicely Melo da Costa, Cláudio Meneghetti, Norma Vasconcelos Saldanha Marinho, Alfredo José Mansur, José Antonio Franchini Ramires, Edimar Alcides Bocchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia (SBC)
2000-03-01
|
Series: | Arquivos Brasileiros de Cardiologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2000000300005 |
Similar Items
-
Real-World Use of Carvedilol in Children With Dilated Cardiomyopathy: Long-Term Effect on Survival and Ventricular Function
by: Rachele Adorisio, et al.
Published: (2022-04-01) -
Clínica de cães com cardiomiopatia dilatada idiopática, tratados ou não com carvedilol Clinic of dogs with dilated cardiomyopathy (DCM) treated or not by carvedilol
by: Moacir Leomil Neto, et al.
Published: (2011-04-01) -
Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials
by: Ayman Elbadawi, et al.
Published: (2019-10-01) -
Thyrotoxicosis and dilated cardiomyopathy in developing countries
by: Bisrat Tesfay Abera, et al.
Published: (2021-06-01) -
The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
by: Tao Liu, et al.
Published: (2023-01-01)